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INTRODUCTION 
 
Veterinarian perform a thorough examination, arrived 
at a correct diagnosis and recommended an appropriate 
treatment but poor compliance (Barter et al., 1996) from the 
owners and/or pets to the advice given will potentially 
cause therapeutic failure. Long-term medication of tablets 
prescription to companion animals are particularly 
challenging especially in non-compliant pet (i.e. aggressive, 
fierce, fear biter). The successfulness of a long-term 
treatment is heavily dependent on owner compliance, their 
willingness and ability to administer the prescribed 
medication. Therefore, a suitable and user-friendly way of 
administrating drugs needs to be identified. 
 
Veterinary compounding drugs 
 
In general, tablets are allowed for administration of 
therapy without presence the veterinarians but owners’ or 
companion animals’ compliance can be a problem. Owners 
may fail to administer the tablet properly, their pets may not 
consume the entire tablet or only partial dose was 
administered especially in cats as this species at times can 
be difficult to medicate. To assist drug delivery and to 
encourage compliance, drugs are sometimes compounded 
by veterinarians, veterinary pharmacists or compounding 
pharmacists. To date, many studies and reviews of 
veterinary compound drugs have been published. They 
generally aim to; 1) to enhance consumer convenience and 
compliance; 2) to improve the pharmacokinetics of drugs 
and;3) to assure target and consumer safety (Ahmed and 
Kasraian, 2002; Merton Boothe, 2006; Papich, 2005). 
Drugs have been compounded for veterinary medical use 
because many were not in an ideal form of formulation to 
be used in the species being treated (cats, exotic animals 
and pet birds). To date, there are only a few approved 
veterinary formulations in the market(Hardee and Baggot, 
1998).  
An extemporaneously prepared compounding drug 
alters the original drug dosage formulation for ease of 
administration. Normally, conventional tablets will be 
crushed, capsules reformulated and solution altered to make 
it more convenient and palatable oral dosage formulation. 
Palatability, ways of administration, methods of dispensing 
and frequency of administration are factors that must be 
considered carefully when formulating a compounded oral  
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drug for companion animals. The combination of these 
factors and the oral drug formulations produced must have 
good end result with regards to drug stability, purity and 
potency comparable to the original formulation (Hardee and 
Baggot, 1998; Papich, 2005).  
The need of alternative formulations of drugs in 
veterinary medicine as well as in medical care for humans, 
particularly for use in paediatric patients, has lead to a boost 
of studies being conducted. Researchers have look into 
physiology function of the gastrointestinal tract of 
companion animals with drug performance (Sutton, 2004), 
comparison between different formulations in terms of 
drugs and products (e.g. in different packaging) stability 
assessment (Garner et al., 1994), photosensitivity studies 
(Andrisano et al., 1999), enantioselectivebehaviour and 
stereospecific of drug studies (Landoni et al., 1997; Mehvar 
and Brocks, 2001). There are also published surveys and 
feedbacks on compliance with medication prescribed 
(Barter et al., 1996), palatability studies (Hames et al., 
2008; Litster et al., 2007) and preference of formulation 
(Cohen et al., 2009). However, many have given great 
emphasized on the pharmacokinetics, pharmacodynamic 
and bioavailability of drugs (Arguedas et al., 2008; Beddies 
et al., 2008; Buck et al., 1989; Flammer et al., 2008; Jug et 
al., 2009), all with the ultimate goal of producing a safe and 
suitable compounded oral drug formulation. 
 
Oral formulation 
 
Oral dosage consist of a large proportion of drugs 
formulations. Commonly, oral dosages are prepared in the 
form of solution, emulsion, suspension, gel/paste, powder, 
capsules and tablets. The solution, emulsion and suspension 
are generally in the form of liquid administered orally with 
an aid of a syringe. Where else, the gel and paste are 
semisolid precise oral dosage application on the upper gum 
or palate commonly supplied in pre-loaded calibrated 
syringes. The rate of paste drugs absorption would be 
expected slower than from a liquid but faster than the solid 
dosage form. Capsule is an easily digested and tasteless unit 
dose containers which allow accurate amount of drugs to be 
contain within a capsule. Different oral drug formulations 
such as powders, granules, pellets, suspension, emulsion or 
oils measured could capsulated but commonly intended for 
human usage and often contain an inappropriate dose for 
most animal species. Oral powder formulations are put on 
food during feeding time and must be palatable (Hardee and 
Baggot, 1998).  
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However, conventional tablets are the most widely 
used oral drug administration in small animals. It has 
certain advantages over oral liquid dosage form. A tablet 
contains an equivalent dose of active drug in a compact 
form, easier to administer and usually presents the fewest 
problems with regard to stability. Bioavailability of a drug 
can vary widely among tablets because of the wide range of 
body weight, the total dose requirements of different 
species, the strength of the tablet (amount of the drug 
contained therein) largely determines its suitability for use 
in a particular species. Therefore, tablets are sometimes cut 
to avoid overdosing and this may lead to inaccuracy of 
medication if tables were not divided properly (Hardee and 
Baggot, 1998).  
On top of that, tablet administrations are very 
challenging in non-compliant pets i.e. cats as they are 
notorious for ejection of tablets within second of their 
administration. In this circumstances, formulations such as 
liquid and paste may be better alternative or adding powder 
and granules into the food may be more convenient in non-
compliant cats (Hardee and Baggot, 1998). Therefore, the 
pharmacodynamic, pharmacokinetics and bioavailability of 
different formulations of the same drug should be 
conducted and correlated to owners’ and cats’ compliance. 
It is crucial to determine which formulation would be cats’ 
and owners’ preference, good compliance practiced and 
achieved a good therapeutic effect. This applied the same 
for other species of companion animals too. 
A few veterinary pharmaceutical companies have 
commercially produced drugs in other formulation and 
many veterinarians have compounded drugs in improve 
their therapeutic effectiveness. Veterinarians have assumed 
commonly that compounded oral formulations perform as 
well as the original formulation. However, this assumption 
should be investigated. Improper prescription of 
ineffectively compounded oral drug formulation would 
waste pet owners’ time and potentially put at risk the health 
of the companion animal. Besides that, there is also a lack 
of studies on pet owners and companion animal compliance 
with regards to the usage of compounded oral formulation. 
More studies could provide useful feedback for 
pharmaceutical companies. This could lead to more 
compounded oral formulations of different drugs to be 
marketed and there could be a change in trends in oral drug 
formulation used by veterinarians. 
 
Drug compliance 
 
Drug compliance is generally described as the 
adherence of patients to their prescribed medication in 
human medicine (Besch, 1995; Cramer and Spilker, 1991; 
Haynes et al., 1979). Therefore, drug compliance in 
veterinary medicine can be defined as the extent to which 
owners adhere to instruction when giving prescribed drugs 
to their animals. To date, veterinary drug compliance in 
veterinary medicine has been reported to range from 44% to 
55% and human medicine has a wider percentage in 
comparison at 5% to 96% (Berendsen and Knol, 2002; 
Cramer and Spilker, 1991). The range of compliance 
supports the speculation in human medicine that patients do 
not adhere strictly to instructions for the use of medication. 
Poor compliance with drug therapy is widespread in all 
aspects of human medicine due to many factors (Cramer 
and Spilker, 1991; Haynes et al., 1979; Mackner and 
Crandall, 2005). As animals are dependent upon their 
owner for administration of medication, there is every 
reason to assume that non-compliance is prevalent in 
veterinary medicine. 
Therefore, alternative compounded drugs produced 
which have comparable or superior pharmacokinetic or 
pharmacodynamic to its original form should be 
investigated. The new alternative compounded formulation 
that may probably be not user friendly would defeat the 
purpose of effective therapeutic treatment and aid in 
compliance. 
 
How to assess levels of compliance in veterinary 
medicine 
 
Drug compliance has been measured and methods 
have been compared in several ways to assess levels of 
compliance directly (e.g. measurements of drugs in blood 
and urine excretion, measurements of biological or inert 
markers) or indirectly (e.g. therapeutic outcomes, clinical 
opinions, interviews, filling of prescriptions, pill counts, 
microelectronic monitors) (Besch, 1995; Cramer and 
Spilker, 1991; Haynes et al., 1979). There is no one valid, 
reliable or novel method to assess drug compliance levels in 
veterinary and human medicine (Andersen et al., 1995; 
Barter et al., 1996; Cramer et al., 1989; D'Souza et al., 
1983; Paes et al., 1998; Partridge et al., 2001; Udelson et 
al., 2009). Most of the studies on drug compliance in 
veterinary medicine are based on short courses of 
medication in dogs (Barter et al., 1996; Bomzon, 1978; 
Grave and Tanem, 1999) and no one has looked at drug 
compliance of cats and pet owners.  
Pill counts were the simplest and cheapest method 
adopted but results obtained could be an over- and 
underestimation of compliance level as pet owners could 
give more pills than required or dispose of them (Bomzon, 
1978; Grave and Tanem, 1999). Electronic monitoring 
involves placing a microchip on the container lid which 
records the number of times the lid was opened in a day. 
This method is expensive and could arouse suspicions as 
the containers looks different from normal dispensing 
containers. Pet owners might remove more than one dose or 
no dose while opening the lid which would reflect over- or 
under dosing (Barter et al., 1996). Compliance in dosing 
intervals can be determined from the electronic monitoring 
which provides objective compliance measurements of 
daily dosing pattern and interval. This assessment is crucial 
as over-, under and erratic dosing intervals can diminish 
drug actions or cause adverse effects (Barter et al., 1996). 
Therapeutic outcomes and monitoring with drug assays 
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using analytical techniques can be used to measured levels 
of compliance but such assays are expensive and subjected 
to individual pharmacokinetic variability. Veterinarians’ 
assessment of client compliance (predictability) has been 
used but the validity of such a subjective and indirect 
measurement is questionable as veterinarians can 
overestimate the level of client compliance (Barter et al., 
1996). Owner self reports, interviews and questionnaires 
are methods by which owners are ask directly or indirectly 
regarding their compliance. These are simple and 
inexpensive methods that can easily be conducted in a 
veterinary practice. These methods allow pet owners to 
express problems encountered during drug administration 
and their observations (Barter et al., 1996; Bomzon, 1978; 
Grave and Tanem, 1999; Litster et al., 2007). 
 
Factors affecting compliance 
 
There are other factors that affect compliance levels 
besides the role of pet owners as administrators. Ease of 
administration is an important consideration when a drug is 
formulated. Generally, cats and dogs are administered 
tablets by placing the tablet at the base of their tongues (far 
back) and gently “poke down” the medication. The pet’s 
mouth is quickly closed, the head returned back to the 
normal position and the throat is massaged or animal is 
distracted till medication is swallowed. Often, this is easier 
said than done particularly in cats as this species is more 
independent and less accustomed to being restrained. Also, 
there is the owners’ fear of being clawed or bitten 
(Thombre, 2004). Therefore, the compliance level tends to 
decrease when a particular formulation is not user-friendly. 
To assist therapeutic treatment, alternative formulations 
which are easy to administer such as oral administration 
(solutions, suspension, paste/gels, capsules, 
powder/granules) (Hardee and Baggot, 1998) and 
transdermal application (ointment, cream, liquid) 
(MacGregor et al., 2008; Magnusson et al., 2001) have 
been compounded to enable owners to independently 
administer.  
Palatability of oral formulations has been found to 
increase compliance level. Studies published in human 
medicine found that palatability is an important factor in 
drug compliance for children where the acceptability and 
ease of medication is greatly affected by its taste (Cifaldi et 
al., 2004; Cohen et al., 2009; Hames et al., 2008). The term 
“palatability” refers to the voluntary (free choice) 
acceptance of ingestion of a pharmaceutical composition by 
companion animals, which is measured by a standard 
palatability test; acceptance and preference testing (Litster 
et al., 2007; Thombre, 2004). Palatability is a desired 
attribute because it affects convenience and compliance, 
especially if medication has to be administered as a lifelong 
therapy e.g. given every day. Palatable oral formulations 
produced by pharmaceutical companies are commonly 
achieved by masking the taste and odour of drugs using 
chemicals, additives and flavourings(Thombre, 2004). 
Other strategies can be adopted to minimise non-
compliance by pet owners such as the clarity of instructions 
of prescription. They should be written clearly and backed 
up verbally to educate pet owners regarding the methods 
and intervals of administration. Changing a treatment 
regime from three times a day to twice daily and choosing a 
more appropriate dose or formulation would enhance 
compliance and effective treatment. Compliance levels also 
increase if owners are given more information regarding the 
condition being treated and the treatment provided if the 
veterinarian has spent sufficient time with pet owners 
during consultation (veterinarian-client-pet relationship) 
(Berendsen and Knol, 2002; Chapman, 1996; Cramer and 
Spilker, 1991; Grave and Tanem, 1999). 
 
CONCLUSION 
 
Oral formulation is a reliable method of 
administration. Currently, tablets at times have been 
substitute by paste and suspension formulation in clinical 
practice in doses equivalent to those given as tablets. To our 
knowledge, many studies has published reporting about 
specific drug plasma concentration and the 
pharmacodynamic effects but not many has looked at other 
formulations in comparison to tablet. Surveys or 
questionnaires documented to quantify owner preference 
and compliance towards different formulation of a drugs 
during administration are limited in veterinary medicine. 
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